Teladoc Health, Inc. TDOC
8.94 USD -0.04 (-0.45%)
At closeNov 11, 2026, 6:35 AM EST
8.95 +0.01 +0.11%
Pre-market · Nov 11, 6:35 AM ET
8.42 Day range 9.01
4.40 52-week range 9.89
- YTD
- +27.71%
- 1 year
- +18.25%
News
benzinga.com TD Cowen Maintains Hold on Teladoc Health, Raises Price Target to $8 TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $6 to $8.- benzinga.com Wells Fargo Maintains Equal-Weight on Teladoc Health, Raises Price Target to $8 Wells Fargo analyst Stan Berenshteyn maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $6 to $8.
benzinga.com Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9 Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.
benzinga.com UBS Maintains Neutral on Teladoc Health, Raises Price Target to $9 UBS analyst Kevin Caliendo maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6.5 to $9.
benzinga.com Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10 Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.
benzinga.com JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10 JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.
benzinga.com Crude Oil Moves Lower; Caterpillar Shares Fall Following Q3 Results U.S. stocks fell Thursday, led by a 9% Caterpillar drop; Porch, Teladoc and Crocs surged, while oil, gold and silver declined.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…
benzinga.com Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.- benzinga.com Stifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5 Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $5.5 to $6.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75%…
benzinga.com Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook Teladoc Health is rising Thursday after it reported better-than-expected Q3 results late Wednesday and raised its 2026 GAAP EPS guidance.
benzinga.com Teladoc Health Stock Rises After Q3 Double Beat Teladoc Health Inc (NYSE:TDOC) shares are rising in Wednesday's after-hours session after the company reports better-than-expected results for the third quarter.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session. Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6…
- benzinga.com Teladoc Health Q3 EPS $(0.15) Beats $(0.21) Estimate, Sales $605.102M Beat $588.477M Estimate Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.21) by 28.57 percent. This is a 46.43 percent increase over losses of…
benzinga.com Teladoc Health Sees Q4 GAAP EPS $(0.23)-$(0.03) vs $(0.11) Est; Sees Sales $569.000M-$615.000M vs $597.389M Est Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.23)-$(0.03) vs $(0.11) analyst estimate. sees sales of $569.000 million-$615.000 million vs $597.389 million analyst estimate.- benzinga.com Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.362 billion-$2.447 billion to…